Strides out for $274m loan as Biocon finds five
Axis Bank has begun sounding out lenders for a $274m loan related to Indian pharmaceutical firm Strides Arcolab's recent acquisition in Australia.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: